Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Hip Replacement Implants Market Size & Growth Forecast 2026–2035, By Segments (End-use, Product Type, Material), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 2435| Published Date: Jan-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Hip Replacement Implants Market size stood at USD 4.98 Billion in 2025 and is predicted to grow at a 2.2% CAGR from 2026 to 2035, surpassing USD 6.19 Billion by 2035. The industry revenue for 2026 is estimated at USD 5.08 billion.

Base Year Value (2025)
USD 4.98 Billion
CAGR (2026-2035)
2.2%
Forecast Year Value (2035)
USD 6.19 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Hip Replacement Implants Market Intelligence Snapshot

Regional Market Dynamics

  • North America leads due to strong orthopedic infrastructure, high procedure volumes, and widespread access to advanced implants across hospitals and ambulatory settings supporting steady demand.
  • Asia Pacific is growing at 2.51% CAGR, driven by improving access to orthopedic surgery, expanding hospital capacity, and gradual adoption of modern implant techniques and procedures.

Segment Momentum

  • Hospitals & Surgery Centers held 67.12% of the market in 2025 due to their comprehensive surgical infrastructure, perioperative care capabilities, and multidisciplinary support required throughout hip replacement procedures.
  • Revision Hip is the fastest-growing product type as more patients require follow-on procedures to address implant wear, loosening, and other complications associated with previous hip replacements.

Market Expansion Drivers

  • Rising osteoarthritis and obesity prevalence increasing demand for hip replacement procedures globally.
  • Advancements in minimally invasive and cement-less hip replacement technologies improving surgical outcomes.
  • Expanding reimbursement coverage improving patient access to orthopedic implant procedures.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Top players in the hip replacement implants market include Zimmer Biomet (United States), Johnson & Johnson (United States), Stryker Corporation (United States), Smith & Nephew plc (United Kingdom), MicroPort Scientific Corporation (China), Exactech, Inc. (United States), OMNIlife Science, Inc. (United States), B. Braun Melsungen AG (Germany), DJO Global, Inc. (United States), Aesculap Implant Systems, LLC (Germany).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising osteoarthritis and obesity prevalence increasing demand for hip replacement procedures globally

The growing burden of osteoarthritis, reinforced by rising obesity rates, is steadily increasing the volume of patients progressing from pain management and mobility support to surgical intervention. In the hip replacement implants market, This trend matters because excess body weight accelerates joint degeneration and often brings earlier functional decline, making conservative treatment less durable over time. As orthopedic surgeons see a broader patient base with advanced hip damage and reduced quality of life, procedure volumes rise and hospitals expand implant procurement to meet demand, directly increasing demand for the market and contributing to market size growth.

Advancements in minimally invasive and cement-less hip replacement technologies improving surgical outcomes

Improved implant design and surgical techniques are changing physician preferences and patient acceptance in ways that strengthen market development. In the hip replacement implants market, minimally invasive approaches are associated with shorter hospital stays, faster recovery, and reduced soft tissue disruption, while cement-less fixation is gaining traction because it supports biological bone ingrowth and long-term implant stability in suitable patients. These clinical advantages influence hospital purchasing decisions and surgeon adoption patterns, increasing market adoption for newer implant systems and aiding market expansion through replacement of older product configurations.

Expanding reimbursement coverage improving patient access to orthopedic implant procedures

Broader reimbursement support reduces one of the main barriers delaying elective joint replacement: out-of-pocket cost exposure. For the hip replacement implants market, stronger coverage from public and private payers allows more patients to move forward with surgery once symptoms become clinically limiting, rather than postponing treatment despite clear need. This has practical effects on procedure conversion rates, referral follow-through, and hospital willingness to invest in implant inventory and orthopedic capacity, reinforcing market demand as access improves across a wider insured population.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising osteoarthritis and obesity prevalence increasing demand for hip replacement procedures globally 1.80% Moderate North America, Europe, Asia Pacific High Near Term
Advancements in minimally invasive and cement-less hip replacement technologies improving surgical outcomes 1.50% High North America, Europe Medium Mid Term
Expanding reimbursement coverage improving patient access to orthopedic implant procedures 1.20% High North America, Europe Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
XX% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

By 2025, North America holds the largest regional share in the hip replacement implants market, supported by its established orthopedic care infrastructure, high procedure volumes, and broad access to advanced implant technologies. The region’s leadership is supported by routine adoption of hip replacement procedures across specialized hospitals and ambulatory surgical settings, where experienced surgeons, standardized care pathways, and favorable access to diagnosis and treatment keep procedural activity steady. This operating environment supports continued demand for premium implants and revision procedures, reinforcing the region’s leading position.

Asia Pacific is projected to expand at a 2.51% CAGR over the forecast period in the hip replacement implants market, with growth accelerating as access to orthopedic surgery improves across major healthcare systems in the region. Rising treatment availability, expanding hospital capacity, and increasing uptake of joint replacement procedures are translating into a larger addressable patient base in practice. Growth is also being impelled by the gradual spread of modern implant techniques and improving surgical capabilities, which are enabling more patients to move from delayed treatment to elective intervention.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Precision Manufacturing Focus

Germany prioritizes high-quality implant engineering supported by strong orthopedic expertise and established medical device manufacturing. Hospitals increasingly value durable implant systems and evidence-based technologies that enhance procedural efficiency and long-term clinical performance.

France 🇫🇷

Clinical Quality Integration

France supports the adoption of hip replacement implants through established orthopedic care pathways and strong emphasis on clinical effectiveness. Healthcare providers continue evaluating implant technologies that balance long-term performance with efficient surgical practices.

Italy 🇮🇹

Specialized Surgical Demand

Italy maintains consistent demand for hip replacement implants through specialized orthopedic centers managing degenerative joint conditions. Clinical priorities include implant durability, surgeon familiarity with proven systems, and techniques that contribute to improved rehabilitation outcomes.

Japan 🇯🇵

Aging Care Solutions

Japan's hip replacement implants market is shaped by growing demand for solutions that address mobility challenges associated with an aging population. Clinical attention remains focused on minimally invasive procedures and implants designed to improve recovery while supporting long-term patient function.

South Korea 🇰🇷

Smart Orthopedic Adoption

South Korea is expanding the use of digitally enabled orthopedic procedures supported by modern hospital infrastructure. Demand for hip replacement implants increasingly favors innovative materials and navigation-assisted surgical techniques that strengthen procedural accuracy and patient care.

United States 🇺🇸

Procedure Innovation Hub

The U.S. emphasizes advanced hip replacement implants that improve surgical precision, implant longevity, and patient recovery. Healthcare providers continue integrating robotic-assisted procedures and data-driven planning to optimize orthopedic treatment outcomes across diverse patient groups.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Hip Replacement Implants Market Share (%), End-use, 2025

Hospitals & Surgery Centers
Orthopedic Clinics
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report
End-use Segment Analysis: Hospitals & Surgery Centers (Largest Segment) vs Orthopedic Clinics (Fastest-Growing Segment)

Hospitals & Surgery Centers held the dominant position in the hip replacement implants market in 2025, accounting for a 67.12% share. Their dominance is sustained by the concentration of operating room infrastructure, perioperative care capabilities, and multidisciplinary support required for hip replacement procedures. This setting is especially important for patient evaluation, implant selection, surgical execution, and post-operative monitoring, which keeps Hospitals & Surgery Centers at the center of procedural volume in the hip replacement implants market.

Orthopedic Clinics are emerging as the fastest-growing end-use segment in the hip replacement implants market as care delivery increasingly shifts toward more specialized and streamlined treatment pathways. Their growth is aided by rising patient preference for focused orthopedic care, faster consultation-to-treatment workflows, and greater procedural specialization compared with broader hospital settings. As providers look for efficient management of musculoskeletal cases, Orthopedic Clinics are gaining momentum by offering a more dedicated environment for diagnosis, follow-up, and procedure planning.

Product Type Segment Analysis: Total Hip (Largest Segment) vs Revision Hip (Fastest-Growing Segment)

In 2025, Total Hip represented the largest product type in the hip replacement implants market with a 39.86% share. Its leadership is anchored in its established use across a wide range of hip degeneration and joint damage cases where full joint replacement remains the standard surgical approach. The segment continues to benefit from consistent procedural adoption, broad surgeon familiarity, and routine integration into treatment protocols, which supports its scale within the hip replacement implants market.

Revision Hip is the fastest-growing product type in the hip replacement implants market, encouraged by the practical need to address implant wear, loosening, and other complications arising after prior hip replacement procedures. Growth in this segment reflects the increasing volume of patients requiring follow-on surgical intervention, making Revision Hip more dynamic than primary alternatives. Its momentum is tied to the expanding installed base of earlier implants and the resulting need for corrective or replacement procedures over time.

Segment Sub-Segment Largest Segment Fastest Growing
End-use Hospitals & Surgery Centers, Orthopedic Clinics, Others Hospitals & Surgery Centers Orthopedic Clinics
Product Type Total Hip, Partial Femoral Head, Hip Resurfacing, Revision Hip Total Hip Revision Hip
Material Metal-on-metal, Metal-on-polyethylene, Ceramic-on-polyethylene, Ceramic-on-metal, Ceramic-on-ceramic Metal-on-polyethylene Ceramic-on-polyethylene
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the hip replacement implants market:

1. Zimmer Biomet (United States)

2. Johnson & Johnson (United States)

3. Stryker Corporation (United States)

4. Smith & Nephew plc (United Kingdom)

5. MicroPort Scientific Corporation (China)

6. Exactech Inc. (United States)

7. OMNIlife Science Inc. (United States)

8. B. Braun Melsungen AG (Germany)

9. DJO Global Inc. (United States)

10. Aesculap Implant Systems LLC (Germany)

The push for higher durability in orthopedics has triggered the introduction of next-generation biocompatible structures designed for younger, more active demographics. This wave of specialized hardware introductions ensures the hip replacement implants market directly addresses long-term wear issues and reduces the likelihood of secondary revision surgeries.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Hip Innovation Technology, LLC Feb-24 Hip Innovation Technology unveiled its flagship Reverse Hip Replacement System (Reverse HRS) at the 2024 AAOS annual meeting. Designed to address instability and dislocation risks, the metal-on-polyethylene system features a unique "reverse" geometry that optimizes stability and range of motion, representing a strategic technological advancement in orthopedic joint reconstruction for complex patient cases.
JointMedica Apr-26 JointMedica reached full enrollment for its U.S. Investigational Device Exemption (IDE) study of the Polymotion Hip Resurfacing System. This bone-conserving technology utilizes a proprietary metal-on-polyethylene articulation to provide a viable alternative to traditional total hip replacement, marking a critical step toward potential commercialization and competitive entry into the hip preservation market.
Smith+Nephew Aug-23 Smith+Nephew launched the OR3O Dual Mobility System in India, introducing a specialized implant design that utilizes a small-diameter femoral head with a large polyethylene insert. This configuration enhances joint stability and range of motion while reducing dislocation risks, strategically strengthening the company’s portfolio for primary and revision hip arthroplasty in the high-growth Asia-Pacific market.
Stryker Aug-23 Stryker initiated a nationwide marketing campaign, “Scan. Plan. Mako Can.,” to drive patient awareness of its Mako SmartRobotics system. By aligning clinical technology with direct-to-patient communication, the initiative aims to increase adoption rates for robotic-assisted hip joint replacement, strengthening the company’s competitive positioning and market share in the digital and robotic-assisted orthopedic surgery segment.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Hip Replacement Implants Market — Custom Segments

Segment Sub-Segment
No segment data available.

Hip Replacement Implants Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the current revenue of the hip replacement implants market?

In 2026 the market for hip replacement implants is valued at USD 5.08 billion.

What is the forecasted size of the hip replacement implants industry?

Hip Replacement Implants Market size is forecast to climb from USD 4.98 billion in 2025 to USD 6.19 billion by 2035 expanding at a CAGR of over 2.2% during 2026-2035.

How are advancements in minimally invasive and cement-less technologies influencing hospital purchasing decisions?

Clinical benefits such as faster recovery, reduced tissue disruption, and improved long-term implant stability are encouraging hospitals and surgeons to adopt newer implant systems while replacing older product configurations.

Why is expanding reimbursement coverage important for growth in the hip replacement implants market?

Broader reimbursement reduces financial barriers to surgery, improving procedure conversion rates, strengthening hospital investment in implant inventory, and expanding orthopedic capacity as more eligible patients proceed with treatment.

Why do Hospitals & Surgery Centers account for the largest share of the hip replacement implants market?

Hospitals & Surgery Centers held 67.12% of the market in 2025 due to their comprehensive surgical infrastructure, perioperative care capabilities, and multidisciplinary support required throughout hip replacement procedures.

What is driving growth in the Revision Hip segment?

Revision Hip is the fastest-growing product type as more patients require follow-on procedures to address implant wear, loosening, and other complications associated with previous hip replacements.

Why is North America the largest market for hip replacement implants?

North America leads due to strong orthopedic infrastructure, high procedure volumes, and widespread access to advanced implants across hospitals and ambulatory settings supporting steady demand.

What factors are supporting Asia Pacific growth in hip replacement implants?

Asia Pacific is growing at 2.51% CAGR, driven by improving access to orthopedic surgery, expanding hospital capacity, and gradual adoption of modern implant techniques and procedures.

Which companies are driving growth in the hip replacement implants landscape?

Top players in the hip replacement implants market include Zimmer Biomet (United States), Johnson & Johnson (United States), Stryker Corporation (United States), Smith & Nephew plc (United Kingdom), MicroPort Scientific Corporation (China), Exactech, Inc. (United States), OMNIlife Science, Inc. (United States), B. Braun Melsungen AG (Germany), DJO Global, Inc. (United States), Aesculap Implant Systems, LLC (Germany).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →